These findings — from a blood test to improvements in drug delivery — may lead to better diagnosis and treatment of the ...

By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), highlighting several recent developments.

Researchers at Johns Hopkins Medicine, led by Bindu Paul, an associate professor of pharmacology, psychiatry and neuroscience at the Johns Hopkins University School of Medicine, reported new evidence ...

Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines. In brain tissue from more than 200 donors, the gene ADAMTS2 was ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Johns Hopkins researchers tie loss of the CSE enzyme to memory decline and Alzheimer’s-like brain damage in mice. (CREDIT: ...

There were breakthroughs in Alzheimer's disease and sleep apnea. From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer's disease, 2025 has been a year full ...

Scientists may have pinpointed a way to reverse Alzheimer’s disease in an animal study. The study, led by University Hospitals Cleveland Medical Center, found that restoring a central cellular energy ...

Scientists have identified two brain receptors that help regulate the breakdown of amyloid beta, a protein linked to Alzheimer’s disease. By influencing a key enzyme involved in clearing these protein ...